Alphaeon to market HD Analyzer in US
The technology is designed to gauge light scatter inside the eye and provide early detection of the existence of a cataract, the release said. In addition, the Optical Scatter Index helps to track cataract progression and objectively measures what a patient sees.
Alphaeon will begin commercializing the device in January. The amount for the license was not disclosed.